SMAD3 and breast carcinoma: In the last step, miRNA microarray analysis was performed to identify differentially expressed miRNAs in each breast cancer subtype, and then it was determined whether they could participate in the regulation of the expression of SMAD3, SMAD4, SMAD5, and SMAD7 selected in previous steps (Table 5).